Dianthus Therapeutics (DNTH) News Today → These AI trades triggered this morning (545% return) (From Prosper Trading Academy) (Ad) Free DNTH Stock Alerts $21.50 +0.51 (+2.43%) (As of 04/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineDianthus Therapeutics (NASDAQ:DNTH) Shares Down 8.9% marketbeat.com - April 24 at 7:14 PMDianthus Therapeutics (NASDAQ:DNTH) Shares Gap Up After Analyst Upgradeamericanbankingnews.com - April 20 at 5:24 AMDianthus Therapeutics (NASDAQ:DNTH) PT Raised to $51.00americanbankingnews.com - April 20 at 4:52 AMWhat 5 Analyst Ratings Have To Say About Dianthus Therapeuticsmarkets.businessinsider.com - April 18 at 2:48 PMDianthus Therapeutics (NASDAQ:DNTH) Price Target Raised to $51.00 at Raymond Jamesmarketbeat.com - April 18 at 1:28 PMDianthus Therapeutics (NASDAQ:DNTH) Shares Gap Up to $23.34marketbeat.com - April 18 at 12:37 PMDianthus Therapeutics (NASDAQ:DNTH) Trading Down 4.6%marketbeat.com - April 17 at 1:52 PMDianthus Therapeutics, Inc. (NASDAQ:DNTH) Sees Significant Increase in Short Interestmarketbeat.com - April 15 at 8:30 AMDianthus Therapeutics (NASDAQ:DNTH) Sees Large Volume Increasemarketbeat.com - April 12 at 3:59 PMDianthus Therapeutics (NASDAQ:DNTH) Trading 4.7% Higher marketbeat.com - April 11 at 1:47 PMDianthus Therapeutics Announces Oral Presentation for DNTH103 at the 2024 American Academy of Neurology (AAN) Annual Meetingglobenewswire.com - April 11 at 7:30 AMDianthus Therapeutics (NASDAQ:DNTH) Shares Down 4.7% marketbeat.com - April 8 at 2:30 PMDianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)globenewswire.com - April 5 at 4:30 PMDianthus Therapeutics (NASDAQ:DNTH) Shares Up 4.9%marketbeat.com - April 5 at 12:51 PMDianthus Therapeutics (NASDAQ:DNTH) Stock Price Down 7.7%marketbeat.com - April 2 at 3:17 PMDianthus Therapeutics, Inc. (NASDAQ:DNTH) Short Interest Updatemarketbeat.com - March 30 at 7:30 PMDianthus Therapeutics (NASDAQ:DNTH) PT Raised to $39.00 at Jefferies Financial Groupmarketbeat.com - March 25 at 12:15 PMDianthus Therapeutics, Inc.: Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q4 and FY2023 Financial Resultsfinanznachrichten.de - March 25 at 12:33 AMAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Xenetic Biosciences (XBIO) and Dianthus Therapeutics (DNTH)markets.businessinsider.com - March 22 at 3:36 PMDianthus Therapeutics Insiders Added US$2.05m Of Stock To Their Holdingsfinance.yahoo.com - March 22 at 10:35 AMWedbush Boosts Dianthus Therapeutics (NASDAQ:DNTH) Price Target to $33.00marketbeat.com - March 22 at 10:25 AMDianthus Therapeutics Highlights Recent Business Achievements and Reports Q4 and FY2023 Financial Resultsglobenewswire.com - March 21 at 4:01 PMEQ Apr 2024 5.000 putfinance.yahoo.com - March 15 at 11:28 PMDianthus Therapeutics Inc DNTHmorningstar.com - March 9 at 8:30 PMDianthus Therapeutics, Inc.: Dianthus Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)finanznachrichten.de - March 8 at 8:33 AMDianthus Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)globenewswire.com - March 7 at 4:30 PMFmr LLC Makes New $28.96 Million Investment in Dianthus Therapeutics, Inc. (NASDAQ:DNTH)marketbeat.com - March 4 at 5:02 AMDianthus Therapeutics, Inc.: Dianthus Therapeutics Announces Initiation of Phase 2 MaGic Trial of DNTH103 In Generalized Myasthenia Gravis (gMG)finanznachrichten.de - February 26 at 12:45 PMDianthus Therapeutics Announces Initiation of Phase 2 MaGic Trial of DNTH103 In Generalized Myasthenia Gravis (gMG)globenewswire.com - February 26 at 7:00 AMDianthus Therapeutics (DNTH) Price Target Increased by 22.22% to 35.53msn.com - February 24 at 2:30 PMSMCI Jan 2025 1310.000 callca.finance.yahoo.com - February 23 at 7:27 PMSMCI Mar 2024 1070.000 callfinance.yahoo.com - February 23 at 7:27 PMAtlas Venture Life Science Advisors LLC Acquires New Position in Dianthus Therapeutics, Inc. (NASDAQ:DNTH)marketbeat.com - February 23 at 5:25 PMDianthus Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conferencemarkets.businessinsider.com - February 23 at 9:27 AMStifel starts Dianthus at buy, cites market potential of lead drugmsn.com - February 15 at 4:23 PMDecoding 4 Analyst Evaluations For Dianthus Therapeuticsbenzinga.com - February 15 at 9:39 AMStifel Nicolaus Begins Coverage on Dianthus Therapeutics (NASDAQ:DNTH)marketbeat.com - February 15 at 7:24 AMDianthus Therapeutics to Participate at the Guggenheim 6th Annual Biotechnology Conferencefinance.yahoo.com - January 31 at 8:37 PMEquities Analysts Set Expectations for Dianthus Therapeutics, Inc.'s FY2028 Earnings (NASDAQ:DNTH)marketbeat.com - January 29 at 2:38 AMWedbush Raises Dianthus Therapeutics (NASDAQ:DNTH) Price Target to $24.00marketbeat.com - January 26 at 9:28 AMDianthus Therapeutics Announces Private Placement Disclosuremsn.com - January 23 at 9:45 AMDianthus Therapeutics Announces $230 Million Private Placementmarkets.businessinsider.com - January 22 at 9:51 AMDianthus Therapeutics Announces PIPE Financing For Around $230 Mln; Stock Up Over 14% In Pre-marketmarkets.businessinsider.com - January 22 at 9:51 AMInstitutional investors in Dianthus Therapeutics, Inc. (NASDAQ:DNTH) have had a wonderful week after share price increased 24%finance.yahoo.com - January 8 at 10:05 AMDianthus Therapeutics to Webcast Presentation at the 42nd Annual J.P. Morgan Healthcare Conferencefinance.yahoo.com - January 2 at 9:05 AMDianthus Therapeutics (NASDAQ:DNTH) Coverage Initiated at Jefferies Financial Groupmarketbeat.com - December 26 at 7:22 AMDNTH Stock Earnings: Dianthus Therapeutics Reported Results for Q3 2023investorplace.com - December 14 at 8:05 AMHere's Why We're Watching Dianthus Therapeutics' (NASDAQ:DNTH) Cash Burn Situationfinance.yahoo.com - December 12 at 10:31 AMDianthus Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)markets.businessinsider.com - December 4 at 6:18 PMDianthus Therapeutics Enhances Leadership Team with Appointment of Jeffrey Stavenhagen, Ph.D., as Chief Scientific Officerfinance.yahoo.com - November 29 at 7:36 PM Get Dianthus Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for DNTH and its competitors with MarketBeat's FREE daily newsletter. Email Address The Best AI Stock to Own in the World Today is Trading for Just $25 (Ad)“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet. See how you can invest alongside him DNTH Media Mentions By Week DNTH Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DNTH News Sentiment▼0.070.32▲Average Medical News Sentiment DNTH News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DNTH Articles This Week▼21▲DNTH Articles Average Week Get Dianthus Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for DNTH and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Bicycle Therapeutics News Nurix Therapeutics News Evolus News Silence Therapeutics News Y-mAbs Therapeutics News PureTech Health News Cogent Biosciences News Disc Medicine News Pharming Group News Savara News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:DNTH) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithWhy Big Pharma is Investing Billions in This BiotechBehind the MarketsJeff Bezos Just Humiliated Elon MuskInvestorPlaceThe only accurate crypto trading system I know …Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dianthus Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
